The proteins which are usually overexpressed (e.g., EGFR, hTERT, p53, carbonic anhydrase IX) are mainly involved in the survival of the cancer cells and therefore are not susceptible to downregulation mechanisms, making them an attractive target for cancer therapeutic approaches [31]. This evidence concerns the gene TP53 and cancer.